0001209191-23-041004.txt : 20230705 0001209191-23-041004.hdr.sgml : 20230705 20230705161456 ACCESSION NUMBER: 0001209191-23-041004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230701 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levin Alyssa CENTRAL INDEX KEY: 0001981854 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 231069072 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (925) 407-1049 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-07-01 0 0001787400 Nkarta, Inc. NKTX 0001981854 Levin Alyssa C/O NKARTA, INC. 6000 SHORELINE COURT, SUITE 102 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks 0 Stock Option (right to buy) 2.19 2023-07-01 4 A 0 442400 0.00 A 2033-06-30 Common Stock 442400 442400 D The option is scheduled to vest and become exercisable as to 25% of the shares subject to the grant on July 1, 2024. The remaining portion of the option is scheduled to vest and become exercisable in 36 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2024. Chief Financial and Business Officer /s/ Alicia Hager, as Attorney-in-Fact 2023-07-05